Discover investment opportunities in $75 AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in $75 AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in $75 AI Stocks using our Smart AI Filter.
8 stocks found for "$75 AI Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.90 | ±66.5% | 65.2 | 0.00% | |||
1.36 | ±73.8% | 285.9 | 0.00% | |||
1.07 | ±33.4% | 24.5 | 0.61% | |||
1.08 | ±51.5% | 30.2 | 0.00% | |||
0.87 | ±40.6% | 75.9 | 0.00% | |||
0.70 | ±32.5% | 18.5 | 0.01% | |||
1.19 | ±68.3% | -57.3 | 0.00% | |||
1.15 | ±56.7% | 238.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes AI stocks like PLTR and AI a focus for growth investors?
A: AI stocks such as Palantir Technologies (PLTR) and C3.ai (AI) are valued for their potential to capitalize on the increasing adoption of artificial intelligence across sectors. These companies offer AI-driven solutions that could enhance operational efficiencies and insights, an appeal for growth investors looking for technology-driven market opportunities.
Q: How do CRM and ADBE stocks benefit from economic cycles?
A: Salesforce (CRM) and Adobe (ADBE) often benefit from economic upswings due to increased enterprise spending on cloud services and digital transformations. Their recurring revenue models provide some stability during downturns, as existing contracts and subscription services maintain a steady cash flow.
Q: Are dividends a significant component of returns for SNOW and MDB?
A: Snowflake (SNOW) and MongoDB (MDB) do not currently pay dividends, focusing instead on reinvesting profits to drive growth. Investors typically look at these stocks for capital appreciation driven by their cloud data and database technologies rather than income generation.
Q: What are the key risks associated with investing in ZS and SPLK?
A: Key risks for Zscaler (ZS) and Splunk (SPLK) involve their reliance on enterprise software subscriptions. Competitive pressures and customer retention challenges could impact growth. Additionally, large-scale data breaches could pose significant risks to their reputations and operational stability.
Q: How do stocks like PATH and MRVL align with technological innovation trends?
A: UiPath (PATH) and Marvell Technology (MRVL) are at the forefront of automation and semiconductor innovations, respectively. Automation aids in streamlining business operations, while semiconductors support growth in 5G, data centers, and automotive industries, aligning with major technology advancement trends.
Q: What competitive advantage does MDB have in the software industry?
A: MongoDB (MDB) offers competitive advantages with its NoSQL database solutions that cater to flexible data modeling, robust scaling, and compatibility with various development frameworks, appealing to businesses transitioning from traditional databases to more agile, cloud-based systems.
Salesforce trails its tech large-cap peers and is the second-worst performer in the Dow this year, ahead of only UnitedHealth. The company's growth rate has been below 10% since mid-2024, and analysts don't expect revenue growth to reach double digits for the latest quarter.
Read moreWhen deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read more